Human interleukin (IL)-17 cytokine-binding peptides
CO20260009128A2Pending Publication Date: 2026-06-30PROTAGONIST THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260009128
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-18
- Filing Date
- 2026-06-19
- Publication Date
- 2026-06-30
Abstract
This description provides peptide compounds that inhibit the human cytokine IL-17. This description also provides pharmaceutical compositions that include these peptide compounds. Furthermore, this description also provides methods of using the peptide compounds, such as methods for treating or preventing diseases, conditions, or disorders mediated by or associated with IL-17.
Need to check novelty before this filing date? Find Prior Art